Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 6Recruiting 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3

Conditions

Breast Neoplasms 71Neoplasms 70Lung Neoplasms 29Prostatic Neoplasms 26Head and Neck Neoplasms 22Colorectal Neoplasms 19Uterine Cervical Neoplasms 17Ovarian Neoplasms 13Neoplasm Metastasis 13Motor Activity 13Fatigue 11Endometrial Neoplasms 11Colonic Neoplasms 11Brain Neoplasms 11Pain 10Carcinoma, Non-Small-Cell Lung 10Multiple Myeloma 9Melanoma 9Rectal Neoplasms 8Leukemia 8Gastrointestinal Neoplasms 8Smoking Cessation 7Pancreatic Neoplasms 7Lymphoma 7Depression 7cyclopia sequence 6Esophageal Neoplasms 6Carcinoma, Renal Cell 6Advanced Cancer 6Uterine Neoplasms 5

Interventions

Cisplatin 90Fluorouracil 76Radiotherapy 63Paclitaxel 58Docetaxel 49Oxaliplatin 48Irinotecan 42Leucovorin 32Capecitabine 31Carboplatin 27Radiation 21Surgical Procedures, Operative 20Esophagectomy 20pembrolizumab 15Neoadjuvant Therapy 15Bevacizumab 15Cetuximab 13Drug Therapy 12Epirubicin 11Chemotherapy, Adjuvant 9S 1 (combination) 8Magnetic Resonance Spectroscopy 8Gemcitabine 8Trastuzumab 7Nivolumab 7Erlotinib Hydrochloride 7Surveys and Questionnaires 6Panitumumab 6Immunohistochemistry 6Chemoradiotherapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Esophageal Neoplasms × Surveys and Questionnaires × Clear all
NCT03246516 2025-12-23

DELOGAST

University Hospital, Lille

Phase NA Completed
258 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01746043 2018-06-06

A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
22 enrolled 11 charts
Gastrointestinal

cyclopia sequence, Esophageal Neoplasms

NCT00867477 2014-08-28

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

M.D. Anderson Cancer Center

Phase 2 Completed
163 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Gastrointestinal Diseases, Lung Neoplasms

NCT00598117 2013-06-27

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

Memorial Sloan Kettering Cancer Center

Completed
409 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01392144 2013-04-04

Phase II Evaluation of Exhaled Nitric Oxide (NO)

M.D. Anderson Cancer Center

Completed
36 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Radiation Pneumonitis

NCT00502502 2012-07-20

Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients

M.D. Anderson Cancer Center

Completed
205 enrolled
GastrointestinalThoracic

Anus Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡